Skip to main content
SpringerLink
Log in

The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Fenbufen [3-(4-biphenylylcarbonyl)propionic acid] was shown to be an orally and parenterally effective nonsteroidal antiinflammatory analgetic and antipyretic agent in animals. Like clinically useful drugs (aspirin, phenylbutazine and indomethacin) it has potent antiinflammatory activity in a wide spectrum of laboratory tests in mice, rats, guinea pigs, and dogs and was of particular interest since it appears to have high analgetic efficacy and a long duration of antiinflammatory and analgetic action. While shown to have ulcerogenic potential in rats at toxic doses, it appeared to have a superior margin of gastrointestinal safety in treatment of dogs with urate synovitis. Evidence was also presented to show that BPAA (4-biphenylacetic acid), a metabolite of fenbufen, has a similar profile of antiinflammatory activity, although appearing to produce slightly more gastrointestinal injury. It appears that BPAA may be the agent responsible for at least part of fenbufen's pharmacologic effects. The data presented suggest that fenbufen has the potential to be used safely and effectively to provide relief for patients with inflammatory disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scherer, R.A. 1974. Aryl and heteroarylcarboxylic acids.In Antiinflammatory Agents, Chemistry and Pharmacology, Vol. I. R. Scherer and M. Whitehouse, editors. Academic Press, New York, 45.

    Google Scholar 

  2. Juby, P.F. 1974. Aryl and heteroarylalkanoic acids and related compounds.In Antiinflammatory Agents, Chemistry and Pharmacology, Vol. I. R. Scherer and M. Whitehouse, editors. Academic Press, New York, 91.

    Google Scholar 

  3. Shen, T.Y., E.A. Ham, V.J. Cirillo, andM. Zanetti. 1974. Structure-activity relationship of certain prostaglandin synthetase inhibitors.In Prostaglandin Synthetase Inhibitors. H.J. Robinson and J.R. Vane, editors. Raven Press, New York, 19.

    Google Scholar 

  4. Gryglewski, R.J. 1974. Structure-activity relationships of some prostaglandin synthetase inhibitors.In Prostaglandin Synthetase Inhibitors. H.J. Robinson and J.R. Vane, editors. Raven Press, New York, 33.

    Google Scholar 

  5. Winter, C.A., E.A. Risley, andG.W. Nuss. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs.Proc. Soc. Exp. Biol. Med. 111:544.

    Google Scholar 

  6. Winder, C.V., J. Wax, V. Burr, M. Been, andC.E. Rosiere. 1958. A study of pharmacological influences on ultraviolet erythema in guinea pigs.Arch. Intern. Pharmacodyn. 116:261.

    Google Scholar 

  7. Newbould, B. 1963. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant.Br. J. Pharmacol. Chemother. 21:127.

    Google Scholar 

  8. Ward, J., andR.S. Cloud, 1966. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats.J. Pharmacol. Exp. Ther. 152:116.

    Google Scholar 

  9. McCarty, D.J., Jr., andJ.A. Faires. 1963. A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters-a bioassay technique.Curr. Ther. Res. 5:284.

    Google Scholar 

  10. Winter, C.A. 1965. Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents.In International Symposium on Non-Steroidal AntiInflammatory Drugs, International Congress Series, No. 82. S. Garattini and M.N.G. Dukes, editors. Excerpta Medica Foundation, Amsterdam, 190.

    Google Scholar 

  11. Hendershot, L.C., andJ. Forsaith. 1958. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesic and nonanalgesics.J. Pharmacol. Exp. Ther. 125:237.

    Google Scholar 

  12. Randall, L.O., andJ.J. Selitto. 1957. A method for measurement of analgesic activity on inflamed tissue.Arch. Intern. Pharmacodyn. 111:409.

    Google Scholar 

  13. D'Amour, F.E., andD.L. Smith. 1941. A method for determining loss of pain sensation.J. Pharmacol. Exp. Ther. 72:74.

    Google Scholar 

  14. Woolfe, G., andA.D. MacDonald. 1944. The evaluation of the analgesic action of pethidine hydrochloride (Demerol).J. Pharmacol. Exp. Ther. 80:300.

    Google Scholar 

  15. Eddy, N.B., C.F. Touchberry, andJ.E. Lieberman, 1950. Synthetic analgesics. I. Methadone isomers and derivatives.J. Pharmacol. Exp. Ther. 98:121.

    Google Scholar 

  16. Abdel-Galil, A.A.A., andP.B. Marshall. 1968. Phenylbutazone and histamine formation in rat glandular stomach: Its relationship to gastric ulceration.Br. J. Pharmacol. Chemother. 33:1.

    Google Scholar 

  17. Peterfalvi, M., R. Deraedt, J. Benzoni, L. Chiflot, andR. Fournex. 1975. Floctafenine, a new non-narcotic analgesic.Arch. Intern. Pharmacodyn. 216:97.

    Google Scholar 

  18. Brodie, D.A., P.G. Cook, B.J. Bauer, andG.E. Dagle. 1970. Indomethacin-induced intestinal lesions in the rat.Toxicol App. Pharmacol. 17:615.

    Google Scholar 

  19. Santos, G.W., andA.H. Owens. 1962. The effect of certain alkylating agents and antimetabolites on the primary agglutinin of rats injected with sheep erythrocytes.Blood 20:111.

    Google Scholar 

  20. Judd, K.P., andJ.J. Trentin. 1971. Cardiac transplantation in mice. II. Effect of continuous immunosuppressive therapy on the survival of H-2 incompatible allografts.Transplantation 11:303.

    Google Scholar 

  21. Louyot, P., J.N. Tamisier, andJ. Pourel. 1974. Experimentation clinique du bucloxate de calcium (804CB) en rhumatologie.Arzneim. Forsch. 24:1428.

    Google Scholar 

  22. Sunshine, A. 1975. Analgesic value of fenbufen in postoperative patients. A comparative oral analgesic study of fenbufen, aspirin and placebo.Clin. Pharmacol. 15:591.

    Google Scholar 

  23. Tolman, E.L., andR. Partridge. 1975. Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents.Prostaglandins 9:349.

    Google Scholar 

  24. Chiccarelli, F.S., and H.Eisner. Personal communication.

  25. Ferreira, S.H., andJ.R. Vane. 1974. New aspects of the mode of action of non-steroid anti-inflammatory drugs.Annu. Rev. Pharmacol. 14:57.

    Google Scholar 

  26. Molina, J., F. Chalem, andM. Pena. 1975. Fenbufen in the treatment of rheumatoid arthritis: A controlled double-blind crossover study. Abstract in the VIII European Rheumatology Congress.Scand. J. Rheum. Suppl. 8, 4.

    Google Scholar 

  27. De Salcedo, I., L.F. Arias, andB.P. Greenberg. 1975. Fenbufen, a new nonsteroidal anti-inflammatory agent: Comparison with phenylbutazone in rheumatoid arthritis.Curr. Ther. Res. 18:295.

    Google Scholar 

  28. Shen, T.Y. 1974. Nonacidic antiarthritic agents and the search for new classes of agents.In Antiinflammatory Agents, Chemistry and Pharmacology, Vol. I. R. Scherrer and M. Whitehouse, editors. Academic Press, New York, 180.

    Google Scholar 

  29. Wax, J., W.A. Clinger, P. Varner, P. Bass, andC.V. Winder. 1970. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid.Gastroenterology. 58:772.

    Google Scholar 

  30. Phelps, P. 1970. Polymorphonuclear leucocyte motility in vitro.Arthritis Rheum. 13:1.

    Google Scholar 

  31. Agudelo, C.A., H.R. Schumacher, andP. Phelps. 1972. Effect of exercise on urate crystal-induced inflammation in canine joints.Arthritis Rheum. 15:609.

    Google Scholar 

  32. Greaves, M.W., andJ. Sondergaard. 1970. A new pharmacological finding in human contact eczema.Arch. Dermatol. 101:659.

    Google Scholar 

  33. Snyder, D.S., andW.H. Eaglstein. 1974. Intradermal antiprostaglandin agents and sunburn.J. Invest. Dermatol. 62:47.

    Google Scholar 

  34. Tolman, E.L., J.E. Birnbaum, F.S. Chiccarelli, J. Panagides, andA.E. Sloboda. 1976. Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.In Advances in Prostaglandin and Thromboxane Research, Vol. 1, B. Samuelsson and R. Paoletti, editors. Raven Press, New York, 133.

    Google Scholar 

  35. Child, R.G., A.C.Osterberg, A.E.Sloboda, and A.S.Tomcufcik. A new antiinflammatory analgesic arylalkanoic acid. 3-(4-biphenylylcarbonyl) propionic acid, fenbufen. Synthesis and structure-activity relationships of analogs.J. Pharm. Sciences. In press.

Download references

Author information

Authors and Affiliations

  1. A Division of American Cyanamid Company, Lederle Laboratories, Pearl River, New York

    Adolph E. Sloboda & Arnold C. Osterberg

Authors
  1. Adolph E. Sloboda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arnold C. Osterberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

U.S. adopted name.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sloboda, A.E., Osterberg, A.C. The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents. Inflammation 1, 415–438 (1976). https://doi.org/10.1007/BF00920340

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00920340

Keywords

Search

Navigation